+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Resorbable Pericardial Membrane Market - Global Forecast to 2030- Product Image
Resorbable Pericardial Membrane Market - Global Forecast to 2030- Product Image
New

Resorbable Pericardial Membrane Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6084704
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Resorbable pericardial membranes are emerging as a pivotal solution in cardiac surgery, offering surgeons and patients a bioengineered scaffold that integrates seamlessly with native tissue. Engineered to support natural healing processes, these membranes minimize postoperative complications, such as inflammation and adhesion formation, while promoting tissue regeneration. The convergence of advanced biomaterials science and precision manufacturing has unlocked new possibilities for pericardial reconstruction, cardiac repair, and tissue engineering applications. As cardiovascular diseases remain the leading cause of mortality worldwide, the demand for next-generation pericardial solutions continues to intensify. This introduction outlines the unique benefits of resorbable membranes, sets the stage for deeper insights into industry dynamics, and highlights the strategic importance of understanding tariff impacts, segmentation patterns, regional performance, and competitive positioning.

Transformative Shifts in Pericardial Membrane Technology

The landscape of pericardial membrane technology has undergone dramatic transformation driven by breakthroughs in material science and manufacturing. First, the shift from traditional biologic grafts to engineered animal-derived and synthetic polymers has enhanced consistency, safety, and performance under physiologic loads. Parallel advancements in decellularization techniques, including detergent and enzymatic treatments, now deliver ultra-clean scaffolds with preserved extracellular matrix cues. Moreover, cross-linking methods have evolved to fine-tune resorption kinetics, and sterilization approaches ensure regulatory compliance without compromising material integrity. Digital innovations in bioprinting and automated processing have reduced variability and accelerated product development cycles. Finally, a strategic emphasis on controlled resorption rates, superior structural integrity, and anti-inflammatory properties has redefined clinical expectations for pericardial repair solutions. Collectively, these shifts are reshaping market dynamics and setting a new standard for patient-centric cardiac care.

Cumulative Impact of United States Tariffs 2025

The imposition of United States tariffs in 2025 has significantly altered the competitive landscape for resorbable pericardial membranes. By increasing import duties on animal-derived bovine, equine, and porcine sources, as well as synthetic polymers like polycaprolactone and polylactic acid, raw material costs have risen, compelling suppliers to reevaluate sourcing strategies. Higher tariffs on imported sterilization and decellularization consumables have prompted manufacturers to internalize critical processing steps, driving investment in in-house cross-linking and sterilization infrastructure. Simultaneously, domestic production incentives have spurred regional partnerships between material innovators and cardiac centers, while some multinational companies have relocated portions of their supply chain to the Americas to mitigate duty impacts. Ultimately, these measures have accelerated vertical integration and fostered robust collaborations that aim to optimize cost structures and ensure uninterrupted device availability for clinicians and patients.

Key Segmentation Insights

An in-depth analysis across multiple segmentation criteria reveals how diverse factors influence market positioning and product development. When examining material source, animal-derived options-spanning bovine, equine, and porcine-continue to benefit from abundant clinical legacy data, whereas synthetic derived scaffolds based on polycaprolactone and polylactic acid offer unmatched batch consistency and customizable resorption profiles. Under material processing, innovations in cross-linking technology complement decellularization techniques-including both detergent treatment and enzymatic treatment-and advanced sterilization approaches that safeguard matrix bioactivity. Application type segmentation highlights that cardiac repair, subdivided into minimally invasive and open heart procedures, remains the primary adoption driver, while pericardial reconstruction grows in elective surgeries, and tissue engineering applications, such as adjunctive support and regenerative applications, are emerging as future growth frontiers. Regarding manufacturing technology, automated processes bolster throughput and quality, bioprinting technology enables design freedom for complex geometries, and conventional processes-encompassing both batch processing and manual processing-remain integral for niche customizations. In terms of end-use specialty, university cardiac centers lead early adoption, research laboratories accelerate material validation, and specialized surgical institutes pioneer novel clinical protocols. Crucially, material properties such as controlled resorption, enhanced flexibility, high biocompatibility, and superior structural integrity define the core value proposition. Lastly, application benefits including accelerated healing, anti-inflammatory effects, and reduced adhesion underscore the clinical rationale for switching to advanced resorbable membranes.

Key Regional Insights

Regional performance exhibits distinct dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong reimbursement frameworks and a concentration of leading cardiac centers drive rapid adoption of premium scaffolds, while local manufacturing hubs benefit from tariff-related reshoring incentives. Europe, the Middle East & Africa present a heterogeneous regulatory landscape where CE-marked devices gain traction through competitive tendering, and governmental initiatives support innovation in university hospitals and specialized institutes. In Asia-Pacific, burgeoning healthcare infrastructure, expanding research laboratory networks, and rising investments in regenerative medicine catalyze demand for cost-effective synthetic scaffolds. Collaborative efforts among local manufacturers, global players, and governmental bodies further accelerate market penetration across emerging economies, underscoring the region’s pivotal role in shaping long-term growth trajectories.

Key Companies Insights

The competitive arena features an array of established multinational corporations and agile innovators. Abbott Laboratories and Acelity have consistently leveraged their extensive distribution channels to integrate bovine and porcine scaffolds into cardiac repair workflows, while Allergan Inc. explores synthetic platforms in partnership with Becton, Dickinson and Company to refine decellularization protocols. Biotissue Technologies Ltd and Boston Scientific Corporation focus on adjunctive support membranes that deliver anti-inflammatory benefits. Cook Medical and Edwards Lifesciences Corporation collaborate on open heart reconstruction devices, supported by GE Healthcare’s imaging and process monitoring solutions. Integra LifeSciences Holdings Corporation and Johnson & Johnson Medical Devices Companies emphasize cross-linking enhancements, while Lifecell Laboratories, LivaNova PLC, and Medigenics Solutions invest in scalable automated and bioprinting processes. Medtronic, Inc., Nipro Corporation, and Novatech Biosciences optimize batch processing for specialized applications, and Olympus Corporation alongside Philips Healthcare enhance intraoperative visualization for minimally invasive procedures. Renowned Medical Device Inc., Resorbable Innovations Inc., and ResorbX Inc. lead the charge in regenerative adjuncts, while Siemens Healthineers and Sientra Inc. pioneer advanced sterilization and quality assurance systems. St. Jude Medical and Stryker Corporation focus on superior structural integrity, Terumo Corporation and TissueTech Innovations prioritize high biocompatibility, and W. L. Gore & Associates integrates reduced-adhesion coatings. Finally, ZOLL Medical Corporation explores novel anti-inflammatory delivery mechanisms, rounding out a landscape where collaboration and differentiation drive competitive advantage.

Actionable Recommendations for Industry Leaders

Industry leaders must adopt a proactive stance to secure their position in this evolving market. First, investing in hybrid material portfolios that combine animal-derived ECM benefits with synthetic polymer consistency will address diverse clinical needs. Second, integrating decellularization, cross-linking, and sterilization capabilities under one roof reduces reliance on external vendors and ensures quality control. Third, forging strategic alliances with university cardiac centers and research laboratories accelerates product validation and clinical adoption. Fourth, expanding automated and bioprinting production lines enhances scalability while maintaining customization options for specialty institutes. Fifth, aligning regional manufacturing footprints with tariff-driven incentives in the Americas and regulatory harmonization efforts in EMEA supports cost-effective supply chains. Finally, prioritizing digital tools for real-time process monitoring and patient outcome tracking will reinforce the value proposition and drive differentiated service models.

Conclusion on Strategic Imperatives

Resorbable pericardial membranes represent a transformative advance in cardiac care, blending material innovation with precision manufacturing to deliver superior clinical outcomes. The convergence of segmentation insights, tariff-driven supply chain shifts, and regional dynamics underscores a complex yet opportunity-rich environment. Companies that master integrated processing, leverage advanced manufacturing technologies, and cultivate strategic partnerships will lead the next wave of innovation. As the industry grapples with evolving regulatory frameworks and escalating demand for patient-centric solutions, robust collaboration across stakeholders-from material scientists to cardiac surgeons-will be essential. Embracing these trends today ensures sustainable growth, enhances therapeutic efficacy, and ultimately elevates the standard of care for patients worldwide.

Market Segmentation & Coverage

This research report categorizes the Resorbable Pericardial Membrane Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Animal Derived
    • Bovine
    • Equine
    • Porcine
  • Synthetic Derived
    • Polycaprolactone
    • Polylactic Acid
  • Cross Linking Technology
  • Decellularization Technique
    • Detergent Treatment
    • Enzymatic Treatment
  • Sterilization Approach
  • Cardiac Repair
    • Minimally Invasive
    • Open Heart
  • Pericardial Reconstruction
  • Tissue Engineering
    • Adjunctive Support
    • Regenerative Applications
  • Automated Process
  • Bioprinting Technology
  • Conventional Process
    • Batch Processing
    • Manual Processing
  • Cardiac Centers
    • University Cardiac Centers
  • Research Laboratories
  • Specialized Surgical Institutes
  • Controlled Resorption
  • Enhanced Flexibility
  • High Biocompatibility
  • Superior Structural Integrity
  • Accelerated Healing
  • Anti Inflammatory Effects
  • Reduced Adhesion

This research report categorizes the Resorbable Pericardial Membrane Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Resorbable Pericardial Membrane Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Acelity
  • Allergan Inc.
  • Becton, Dickinson and Company
  • Biotissue Technologies Ltd
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Medical Devices Companies
  • Lifecell Laboratories
  • LivaNova PLC
  • Medigenics Solutions
  • Medtronic, Inc.
  • Nipro Corporation
  • Novatech Biosciences
  • Olympus Corporation
  • Philips Healthcare
  • Renowned Medical Device Inc.
  • Resorbable Innovations Inc.
  • ResorbX Inc.
  • Siemens Healthineers
  • Sientra Inc.
  • St. Jude Medical
  • Stryker Corporation
  • Terumo Corporation
  • TissueTech Innovations
  • W. L. Gore & Associates
  • ZOLL Medical Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Resorbable Pericardial Membrane Market, by Material Source
8.1. Introduction
8.2. Animal Derived
8.2.1. Bovine
8.2.2. Equine
8.2.3. Porcine
8.3. Synthetic Derived
8.3.1. Polycaprolactone
8.3.2. Polylactic Acid
9. Resorbable Pericardial Membrane Market, by Material Processing
9.1. Introduction
9.2. Cross Linking Technology
9.3. Decellularization Technique
9.3.1. Detergent Treatment
9.3.2. Enzymatic Treatment
9.4. Sterilization Approach
10. Resorbable Pericardial Membrane Market, by Application Type
10.1. Introduction
10.2. Cardiac Repair
10.2.1. Minimally Invasive
10.2.2. Open Heart
10.3. Pericardial Reconstruction
10.4. Tissue Engineering
10.4.1. Adjunctive Support
10.4.2. Regenerative Applications
11. Resorbable Pericardial Membrane Market, by Manufacturing Technology
11.1. Introduction
11.2. Automated Process
11.3. Bioprinting Technology
11.4. Conventional Process
11.4.1. Batch Processing
11.4.2. Manual Processing
12. Resorbable Pericardial Membrane Market, by End Use Specialty
12.1. Introduction
12.2. Cardiac Centers
12.2.1. University Cardiac Centers
12.3. Research Laboratories
12.4. Specialized Surgical Institutes
13. Resorbable Pericardial Membrane Market, by Material Properties
13.1. Introduction
13.2. Controlled Resorption
13.3. Enhanced Flexibility
13.4. High Biocompatibility
13.5. Superior Structural Integrity
14. Resorbable Pericardial Membrane Market, by Application Benefits
14.1. Introduction
14.2. Accelerated Healing
14.3. Anti Inflammatory Effects
14.4. Reduced Adhesion
15. Americas Resorbable Pericardial Membrane Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Resorbable Pericardial Membrane Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Resorbable Pericardial Membrane Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Acelity
18.3.3. Allergan Inc.
18.3.4. Becton, Dickinson and Company
18.3.5. Biotissue Technologies Ltd
18.3.6. Boston Scientific Corporation
18.3.7. Cook Medical
18.3.8. Edwards Lifesciences Corporation
18.3.9. GE Healthcare
18.3.10. Integra LifeSciences Holdings Corporation
18.3.11. Johnson & Johnson Medical Devices Companies
18.3.12. Lifecell Laboratories
18.3.13. LivaNova PLC
18.3.14. Medigenics Solutions
18.3.15. Medtronic, Inc.
18.3.16. Nipro Corporation
18.3.17. Novatech Biosciences
18.3.18. Olympus Corporation
18.3.19. Philips Healthcare
18.3.20. Renowned Medical Device Inc.
18.3.21. Resorbable Innovations Inc.
18.3.22. ResorbX Inc.
18.3.23. Siemens Healthineers
18.3.24. Sientra Inc.
18.3.25. St. Jude Medical
18.3.26. Stryker Corporation
18.3.27. Terumo Corporation
18.3.28. TissueTech Innovations
18.3.29. W. L. Gore & Associates
18.3.30. ZOLL Medical Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix

List of Figures
FIGURE 1. RESORBABLE PERICARDIAL MEMBRANE MARKET MULTI-CURRENCY
FIGURE 2. RESORBABLE PERICARDIAL MEMBRANE MARKET MULTI-LANGUAGE
FIGURE 3. RESORBABLE PERICARDIAL MEMBRANE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. RESORBABLE PERICARDIAL MEMBRANE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. RESORBABLE PERICARDIAL MEMBRANE MARKET, FPNV POSITIONING MATRIX, 2024


List of Tables
TABLE 1. RESORBABLE PERICARDIAL MEMBRANE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CROSS LINKING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DETERGENT TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ENZYMATIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STERILIZATION APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY OPEN HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PERICARDIAL RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ADJUNCTIVE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY REGENERATIVE APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AUTOMATED PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY BIOPRINTING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY BATCH PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUAL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY UNIVERSITY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SPECIALIZED SURGICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONTROLLED RESORPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ENHANCED FLEXIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HIGH BIOCOMPATIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SUPERIOR STRUCTURAL INTEGRITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ACCELERATED HEALING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANTI INFLAMMATORY EFFECTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY REDUCED ADHESION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 98. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 99. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 100. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 101. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 102. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 103. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 105. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 106. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 108. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 109. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 110. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 111. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 114. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 115. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 116. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 119. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 120. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 122. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 123. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 125. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 169. AUSTRALIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 170. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 171. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 172. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 173. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 174. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 175. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 176. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 177. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 178. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 180. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 181. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 182. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 183. CHINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 184. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 185. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 186. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 187. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 188. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 189. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 190. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 191. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 192. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 194. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 195. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 196. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 197. INDIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 211. INDONESIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 212. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 213. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 214. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 215. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 216. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 217. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 218. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 219. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 220. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 223. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 224. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 225. JAPAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 232. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 233. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 234. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 236. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 237. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 238. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 239. MALAYSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 257. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USE SPECIALTY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 281. SOUTH KOREA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION BENEFITS, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL SOURCE, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 284. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SYNTHETIC DERIVED, 2018-2030 (USD MILLION)
TABLE 285. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL PROCESSING, 2018-2030 (USD MILLION)
TABLE 286. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DECELLULARIZATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 287. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 288. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC REPAIR, 2018-2030 (USD MILLION)
TABLE 289. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 290. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. TAIWAN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CONVENTIONAL PROCESS, 2018-2030 (USD MILLION)
TABLE 292. TAIWAN RESORBABLE PERICARDIAL MEMBRA

Companies Mentioned

  • Abbott Laboratories
  • Acelity
  • Allergan Inc.
  • Becton, Dickinson and Company
  • Biotissue Technologies Ltd
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Medical Devices Companies
  • Lifecell Laboratories
  • LivaNova PLC
  • Medigenics Solutions
  • Medtronic, Inc.
  • Nipro Corporation
  • Novatech Biosciences
  • Olympus Corporation
  • Philips Healthcare
  • Renowned Medical Device Inc.
  • Resorbable Innovations Inc.
  • ResorbX Inc.
  • Siemens Healthineers
  • Sientra Inc.
  • St. Jude Medical
  • Stryker Corporation
  • Terumo Corporation
  • TissueTech Innovations
  • W. L. Gore & Associates
  • ZOLL Medical Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Collagen Dental Membrane Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Collagen Dental Membrane Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
ECMO Hollow Fiber Membrane Market by Product Type (Hydrophobic Membrane, Microporous Membrane, Poreless Membrane), Material (Polyetheretherketone (PEEK), Polypropylene, Polysulfone), Application, End User - Global Forecast 2025-2030 - Product Image

ECMO Hollow Fiber Membrane Market by Product Type (Hydrophobic Membrane, Microporous Membrane, Poreless Membrane), Material (Polyetheretherketone (PEEK), Polypropylene, Polysulfone), Application, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Synthetic Graphite Heat - Dissipation Membrane Market - Global Forecast to 2030 - Product Image

Synthetic Graphite Heat - Dissipation Membrane Market - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global, United States Global, United States
From
Microfiltration Membranes Market by Membrane Type (Hollow Fiber Membranes, Plate-and-Frame Membranes, Spiral-Wound Membranes), Material Type (Ceramic Membranes, Polymeric Membranes), Filtration Mode, Pore Size, Application - Global Forecast 2025-2030 - Product Image

Microfiltration Membranes Market by Membrane Type (Hollow Fiber Membranes, Plate-and-Frame Membranes, Spiral-Wound Membranes), Material Type (Ceramic Membranes, Polymeric Membranes), Filtration Mode, Pore Size, Application - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Selective Ion-permeable Membranes Market - Global Forecast to 2030 - Product Image

Selective Ion-permeable Membranes Market - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global, United States Global, United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.